Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Replicase polyprotein 1ab (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM423464 (WO2006061714, P38.7 | WO2006061714-ID-09 | cmdc.20...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Experimental Drug Development Centre | Assay Description Please point to the patents. | ChemMedChem (2021) Article DOI: 10.1002/cmdc.202100576 BindingDB Entry DOI: 10.7270/Q27M0C3W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM423464 (WO2006061714, P38.7 | WO2006061714-ID-09 | cmdc.20...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | WIPO WO2005113580 | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. | Assay Description The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O... | WIPO (2005) BindingDB Entry DOI: 10.7270/Q2PV6NRF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (SARS coronavirus Urbani) | BDBM423464 (WO2006061714, P38.7 | WO2006061714-ID-09 | cmdc.20...) | PDB UniProtKB/TrEMBL GoogleScholar AffyNet | PC cid PC sid UniChem | WIPO WO2006061714 | n/a | n/a | 3.20E+4 | n/a | 3.60E+6 | n/a | n/a | n/a | n/a |
Pfizer Inc. | Assay Description Proteolytic activity of Coronavirus 3C protease is measured using a continuous fluorescence resonance energy transfer assay. The SARS 3CI_pro FRET as... | WIPO (2006) BindingDB Entry DOI: 10.7270/Q22V2K5W | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (Human SARS coronavirus (SARS-CoV) (Severe acute re...) | BDBM423464 (WO2006061714, P38.7 | WO2006061714-ID-09 | cmdc.20...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | WIPO WO2005113580 | n/a | n/a | n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a |
Pfizer Inc. | Assay Description Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ... | WIPO (2005) BindingDB Entry DOI: 10.7270/Q2PV6NRF | |||||||||||
More data for this Ligand-Target Pair |